Haemophilus influenzae - Annual Epidemiological Report for 2017
In 2017, 3 888 confirmed cases of invasive Haemophilus influenzae disease were reported in the EU/EEA.
Surveillance systems overview for 2017
- Chikungunya virus disease
- Chlamydia infection
- Crimean-Congo haemorrhagic fever
- Ebola haemorrhagic fever
- Hantavirus infection
- Healthcare-associated infections
- Hepatitis A
- Hepatitis B
- Hepatitis C
- HIV infection
- Invasive Haemophilus influenzae disease
- Lassa fever
- Marburg haemorrhagic fever
- Meningococcal disease
- Pneumococcal disease
- Q fever
- Rift Valley fever
- Severe acute respiratory syndrome (SARS)
- Surgical site infections
- Verotoxigenic Escherichia coli infection
- West Nile virus infection
- Yellow fever
Haemophilus influenzae disease - Annual Epidemiological Report for 2014
Annual Epidemiological Report for Haemophilus influenzae disease, 2014
External quality assessment scheme for Haemophilus influenzae 2014
This report presents the results of an external quality assessment carried out in 2014 to test laboratories’ ability to correctly identify strains of Haemophilus influenzae.
Surveillance of invasive bacterial diseases in Europe, 2012
This report describes the occurrence of invasive bacterial diseases (IBD) in Europe during 2012, based on data collected through The European Surveillance System (TESSy).
Surveillance of invasive bacterial diseases in Europe 2010
This report describes the epidemiology of invasive bacterial disease due to Haemophilus influenzae and Neisseria meningitidis in EU and EEA Member States in 2010.
Surveillance of invasive bacterial diseases in Europe, 2011
This report describes the occurrence of invasive bacterial diseases in Europe during 2011.
External Quality Assurance scheme for Haemophilus influenzae, 2012
In May 2012 a collection of five strains of Haemophilus spp was sent to 28 participating reference laboratories in the IBD-labnet surveillance network for quality assurance testing. The laboratories were asked to characterise the five strains by performing standard laboratory protocols for the methods usually used by the laboratory for: species identification, biotyping and serotyping by serological methods and/or PCR.
The results of this EQA are published in the this report.
External quality assurance scheme for Haemophilus influenzae 2011
The results of this external quality assurance distribution have shown that European Haemophilus reference laboratories differ in the level of characterisation of strains, ranging from simple speciation to full identification and typing. All but two laboratories routinely phenotypically serotype isolates. Fifteen laboratories (52%) performed PCR-based capsular genotyping, 23 laboratories (79%) reported antimicrobial susceptibility testing results.